Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of this study is to determine if there will be a significantly higher incidence of a bowel movement with methylnaltrexone vs. placebo within 4 hours +- 45 minutes with decreased need for rescue medications in the intensive care unit in patients with opioid-induced constipation. Patients will also be managed with an aggressive bowel management protocol.
Epistemonikos ID: eaf50cb455326e0638e3ed8369fa582241e238c0
First added on: May 05, 2024